GlassScriptPhysician profile
Jeffrey Miller
NPI 1053415315
$9,892.53
in general payments reported to CMS, 2019-2025
40 companies · $1,721 in 2025
The $1,721 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,344 · 2020: $929 · 2021: $962 · 2022: $1,531 · 2023: $1,684 · 2024: $1,721 · 2025: $1,721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,026 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,025.95 |
| Education | $100.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,852.19 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $1,250.50 | 2020-2025 | Acthar |
| Amgen INC. | $851.29 | 2019-2025 | Evenity, Uplizna, Otezla |
| Aurinia Pharma U.S., INC. | $726.08 | 2021-2025 | Lupkynis |
| Janssen Biotech, INC. | $526.20 | 2019-2023 | Tremfya, Remicade, Stelara |
| Ucb, INC. | $405.75 | 2020-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $371.71 | 2019-2024 | |
| Ani Pharmaceuticals, INC. | $350.69 | 2022-2025 | Purified Cortrophin Gel |
| Pfizer INC. | $328.85 | 2019-2025 | |
| Radius Health, INC. | $318.50 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $306.36 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $164.57 | 2021-2024 | Fasenra, Saphnelo |
| Novartis Pharmaceuticals Corporation | $158.76 | 2019-2020 | |
| Adma Biomanufacturing LLC | $150.00 | 2024 | |
| Lilly USA, LLC | $149.86 | 2022-2025 | Taltz |
Show all 38 companies
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.